Table 3 Table 3
Biologic medication | Current use | Prior use |
|---|---|---|
| Â | N (% of biologic users) | N (% of biologic users) |
TNF-alpha inhibitirs | Â | Â |
Adalimumab | 78 (7) | 70 (6) |
Cartolizumab | 4 (<1) | 0 |
Etanercept | 214 (20) | 183 (17) |
Gollimumab | 5 (<1) | 4 (<1) |
Inflximab | 46 (4) | 46 (4) |
IL-1 Inhibitors | Â | Â |
Ankira | 14 (1) | 22 (2) |
Rilonacept | 2 (<1) | 2 (<1) |
Other biologic agents | Â | Â |
Abatacept | 24 (2) | 8 (<1) |
Rituximab | 2 (<1) | 8 (<1) |
Tocilizumab | 6 (<1) | 0 (<1) |